missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Thrombopoietin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 288-TP-025/CF
Additional Details : Weight : 0.00970kg
Description
The Recombinant Human Thrombopoietin Protein is derived from Sf 21 (baculovirus). The Recombinant Human Thrombopoietin Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA. | |
35 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
97%, by SDS-PAGE with silver staining. |
7066 | |
Thrombopoietin/Tpo | |
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Thrombopoietin/Tpo protein Ser22-Gly353 | |
Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF | |
Recombinant |